Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Tari Ann King, M.D.

Title
Institution
Department
Address
Phone

Bibliographic
selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Laws A, Kantor O, King TA. Surgical Management of the Axilla for Breast Cancer. Hematol Oncol Clin North Am. 2023 02; 37(1):51-77. PMID: 36435614.
    Citations:    Fields:    Translation:Humans
  2. Weiss A, King TA. Local Regional Recurrence Rates Are Low Following Neoadjuvant Endocrine Therapy: What Are the Remaining Barriers to its Widespread Adoption? Ann Surg Oncol. 2023 Jan 01. PMID: 36587173.
    Citations:    Fields:    
  3. Laws A, Katlin F, Hans M, Graichen M, Kantor O, Minami C, Bychkovsky BL, Pace LE, Scheib R, Garber JE, King TA. ASO Visual Abstract: Screening MRI Does Not Increase Cancer Detection or Result in Earlier Stage at Diagnosis in Patients with High-Risk Breast Lesions-A Propensity Score Analysis. Ann Surg Oncol. 2023 01; 30(1):78-79. PMID: 36222934.
    Citations:    Fields:    Translation:Humans
  4. Garcia-Recio S, Hinoue T, Wheeler GL, Kelly BJ, Garrido-Castro AC, Pascual T, De Cubas AA, Xia Y, Felsheim BM, McClure MB, Rajkovic A, Karaesmen E, Smith MA, Fan C, Ericsson PIG, Sanders ME, Creighton CJ, Bowen J, Leraas K, Burns RT, Coppens S, Wheless A, Rezk S, Garrett AL, Parker JS, Foy KK, Shen H, Park BH, Krop I, Anders C, Gastier-Foster J, Rimawi MF, Nanda R, Lin NU, Isaacs C, Marcom PK, Storniolo AM, Couch FJ, Chandran U, Davis M, Silverstein J, Ropelewski A, Liu MC, Hilsenbeck SG, Norton L, Richardson AL, Symmans WF, Wolff AC, Davidson NE, Carey LA, Lee AV, Balko JM, Hoadley KA, Laird PW, Mardis ER, King TA, Perou CM. Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis. Nat Cancer. 2023 01; 4(1):128-147. PMID: 36585450; PMCID: PMC9886551.
    Citations: 1     Translation:HumansAnimalsCells
  5. Kantor O, Burstein HJ, King TA, Shak S, Russell CA, Giuliano AE, Hortobagyi GN, Winer EP, Korde LA, Sparano JA, Mittendorf EA. ASO Visual Abstract: Expanding Staging Criteria in T1-2N0 Hormone Receptor-Positive Breast Cancer Patients Enrolled in TAILORx. Ann Surg Oncol. 2022 12; 29(13):8024-8025. PMID: 35902504.
    Citations:    Fields:    
  6. Nakhlis F, Katlin FD, Grossmith SC, DiPasquale A, Harrison BT, Schnitt SJ, King TA. ASO Visual Abstract: The Presence of Non-classic LCIS is Not a Contraindication to Breast Conservation in Patients with Concomitant Invasive Breast Cancer or DCIS. Ann Surg Oncol. 2022 11; 29(12):7703-7704. PMID: 35861759.
    Citations: 1     Fields:    
  7. Kantor O, Weiss A, Burstein HJ, Mittendorf EA, King TA. ASO Visual Abstract: Sentinel Lymph Node Biopsy Alone is Adequate for Chemotherapy Decisions in Postmenopausal Early-Stage, Hormone-Receptor-Positive, HER2-Negative Breast Cancer with 1-3 Positive Sentinel Lymph Nodes. Ann Surg Oncol. 2022 11; 29(12):7683-7684. PMID: 35810227.
    Citations:    Fields:    
  8. Nash AL, Thomas SM, Nimbkar SN, Hieken TJ, Ludwig KK, Jacobs LK, Miller ME, Gallagher KK, Wong J, Neuman HB, Tseng J, Hassinger TE, King TA, Hwang ES, Jakub JW, Rosenberger LH. Racial-ethnic variations in phyllodes tumors among a multicenter United States cohort. J Surg Oncol. 2023 Mar; 127(3):369-373. PMID: 36206024; PMCID: PMC9892174.
    Citations:    Fields:    Translation:Humans
  9. Lehman CD, Mercaldo S, Lamb LR, King TA, Ellisen LW, Specht M, Tamimi RM. Deep Learning vs Traditional Breast Cancer Risk Models to Support Risk-Based Mammography Screening. J Natl Cancer Inst. 2022 10 06; 114(10):1355-1363. PMID: 35876790; PMCID: PMC9552206.
    Citations:    Fields:    
  10. Lyu HG, Kantor O, Laws AD, McDonald J, Pham L, Dominici LS, Vincuilla J, Raut CP, Danilchuk B, Novak L, Parker T, King TA, Mittendorf EA. Development of an Electronic Health Record Registry to Facilitate Collection of Commission on Cancer Metrics for Patients Undergoing Surgery for Breast Cancer. JCO Clin Cancer Inform. 2022 10; 6:e2200012. PMID: 36215674.
    Citations:    Fields:    Translation:Humans
  11. Tarantino P, Niman SM, Erick TK, Priedigkeit N, Harrison BT, Giordano A, Nakhlis F, Bellon JR, Parker T, Strauss S, Jin Q, King TA, Overmoyer BA, Curigliano G, Regan MM, Tolaney SM, Lynce F. HER2-low inflammatory breast cancer: Clinicopathologic features and prognostic implications. Eur J Cancer. 2022 10; 174:277-286. PMID: 36116830.
    Citations: 1     Fields:    Translation:Humans
  12. Laws A, Katlin F, Hans M, Graichen M, Kantor O, Minami C, Bychkovsky BL, Pace LE, Scheib R, Garber JE, King TA. Screening MRI Does Not Increase Cancer Detection or Result in an Earlier Stage at Diagnosis for Patients with High-Risk Breast Lesions: A Propensity Score Analysis. Ann Surg Oncol. 2023 Jan; 30(1):68-77. PMID: 36171529.
    Citations:    Fields:    Translation:Humans
  13. Mittendorf EA, Kantor O, Weiss A, Richardson E, Garrido-Castro A, Portnow LH, Krop IE, Lin NU, Winer EP, Tolaney SM, King TA. Nodal Positivity in Early-Stage Triple-Negative Breast Cancer: Implications for Preoperative Immunotherapy. Ann Surg Oncol. 2023 Jan; 30(1):100-106. PMID: 35941343.
    Citations:    Fields:    Translation:Humans
  14. Minami CA, Bryan AF, Freedman RA, Revette AC, Schonberg MA, King TA, Mittendorf EA. Assessment of Oncologists' Perspectives on Omission of Sentinel Lymph Node Biopsy in Women 70 Years and Older With Early-Stage Hormone Receptor-Positive Breast Cancer. JAMA Netw Open. 2022 08 01; 5(8):e2228524. PMID: 36001314; PMCID: PMC9403774.
    Citations:    Fields:    Translation:Humans
  15. Tarantino P, Jin Q, Tayob N, Jeselsohn RM, Schnitt SJ, Vincuilla J, Parker T, Tyekucheva S, Li T, Lin NU, Hughes ME, Weiss AC, King TA, Mittendorf EA, Curigliano G, Tolaney SM. Prognostic and Biologic Significance of ERBB2-Low Expression in Early-Stage Breast Cancer. JAMA Oncol. 2022 08 01; 8(8):1177-1183. PMID: 35737367; PMCID: PMC9227690.
    Citations: 1     Fields:    
  16. Dominici LS, King TA. Surgical Decision-making in Early-Stage Breast Cancer-Trends and Opportunities. JAMA Surg. 2022 08 01; 157(8):711-712. PMID: 35675045.
    Citations:    Fields:    
  17. Weiss A, King C, Vincuilla J, Parker T, Portnow L, Nakhlis F, Dominici L, Mittendorf EA, King TA. Rates of pathologic nodal disease among cN0 and cN1 patients undergoing routine axillary ultrasound and neoadjuvant chemotherapy. Breast Cancer Res Treat. 2022 Sep; 195(2):181-189. PMID: 35900704.
    Citations:    Fields:    
  18. Kantor O, Burstein HJ, King TA, Shak S, Russell CA, Giuliano AE, Hortobagyi GN, Winer EP, Korde LA, Sparano JA, Mittendorf EA. Expanding the Staging Criteria for T1-2N0 Hormone-Receptor Positive Breast Cancer Patients Enrolled in TAILORx. Ann Surg Oncol. 2022 Dec; 29(13):8016-8023. PMID: 35900648.
    Citations:    Fields:    
  19. Weiss A, King TA. What Is the Role of Neoadjuvant Endocrine Therapy for Breast Cancer? Adv Surg. 2022 09; 56(1):275-286. PMID: 36096572.
    Citations: 1     Fields:    Translation:Humans
  20. Singer L, Weiss A, Bellon JR, King TA. Regional Nodal Management After Preoperative Systemic Therapy. Semin Radiat Oncol. 2022 07; 32(3):228-236. PMID: 35688521.
    Citations:    Fields:    Translation:Humans
  21. Nakhlis F, Katlin FD, Grossmith SC, DiPasquale A, Harrison BT, Schnitt SJ, King TA. Presence of Non-classic LCIS Is Not a Contraindication to Breast Conservation in Patients with Concomitant Invasive Breast Cancer or DCIS. Ann Surg Oncol. 2022 Nov; 29(12):7696-7702. PMID: 35771367.
    Citations:    Fields:    
  22. Kantor O, Weiss A, Burstein HJ, Mittendorf EA, King TA. Sentinel Lymph Node Biopsy Alone is Adequate for Chemotherapy Decisions in Postmenopausal Early-Stage Hormone-Receptor-Positive, HER2-Negative Breast Cancer with One to Three Positive Sentinel Lymph Nodes. Ann Surg Oncol. 2022 Nov; 29(12):7674-7682. PMID: 35763229.
    Citations:    Fields:    
  23. Sella T, Kantor O, Weiss A, Partridge AH, Metzger O, King TA. The prevalence and predictors of adjuvant chemotherapy use among patients treated with neoadjuvant endocrine therapy. Breast Cancer Res Treat. 2022 Aug; 194(3):663-672. PMID: 35752703.
    Citations:    Fields:    Translation:Humans
  24. Mittendorf EA, King TA, Tolaney SM. Impact of RxPONDER and monarchE on the Surgical Management of the Axilla in Patients With Breast Cancer. J Clin Oncol. 2022 10 10; 40(29):3361-3364. PMID: 35675571.
    Citations:    Fields:    
  25. Weiss A, King C, Grossmith S, Portnow L, Raza S, Nakhlis F, Dominici L, Barbie T, Minami C, Nimbkar S, Rhei E, Mittendorf EA, King TA. ASO Visual Abstract: How Often Does Retrieval of a Clipped Lymph Node Change Adjuvant Therapy Recommendations? A Prospective Consecutive Patient Cohort Study. Ann Surg Oncol. 2022 06; 29(6):3774-3775. PMID: 35292882.
    Citations:    Fields:    Translation:Humans
  26. Eroglu I, Sevilimedu V, Park A, King TA, Pilewskie ML. Accuracy of the Breast Cancer Surveillance Consortium Model Among Women with LCIS. Breast Cancer Res Treat. 2022 Jul; 194(2):257-264. PMID: 35595928.
    Citations:    Fields:    Translation:Humans
  27. Waks AG, Desai NV, Li T, Poorvu PD, Partridge AH, Sinclair N, Spring LM, Faggen M, Constantine M, Metzger O, Alberti J, Deane J, Rosenberg SM, Frank E, Tolaney SM, Krop IE, Tung NM, Tayob N, King TA, Mittendorf EA, Winer EP. A prospective trial of treatment de-escalation following neoadjuvant paclitaxel/trastuzumab/pertuzumab in HER2-positive breast cancer. NPJ Breast Cancer. 2022 May 10; 8(1):63. PMID: 35538105; PMCID: PMC9091255.
    Citations:    
  28. Mallory MA, Whiting K, Park A, Gönen M, Gilbert E, King TA, Pilewskie ML. Synchronous and metachronous bilateral breast cancer among women with a history of lobular carcinoma in situ. Breast Cancer Res Treat. 2022 Jul; 194(1):137-148. PMID: 35488092.
    Citations:    Fields:    Translation:Humans
  29. Song JH, Kantor O, Mittendorf EA, King TA, Minami CA. ASO Visual Abstract: Race and Site of Care Impact Treatment Delays for Older Women with Non-Metastatic Breast Cancer. Ann Surg Oncol. 2022 Apr 26. PMID: 35474557.
    Citations:    Fields:    
  30. Minami CA, Jin G, Schonberg MA, Freedman RA, King TA, Mittendorf EA. ASO Visual Abstract: Variation in Deescalated Axillary Surgical Practices in Older Women with Early-Stage Breast Cancer. Ann Surg Oncol. 2022 Apr 16. PMID: 35430651.
    Citations:    Fields:    
  31. Minami CA, Jin G, Schonberg MA, Freedman RA, King TA, Mittendorf EA. Variation in Deescalated Axillary Surgical Practices in Older Women with Early-Stage Breast Cancer. Ann Surg Oncol. 2022 Apr 06. PMID: 35385998; PMCID: PMC9982465.
    Citations:    Fields:    
  32. Bychkovsky B, Laws A, Katlin F, Hans M, Knust Graichen M, Pace LE, Scheib R, Garber JE, King TA. Initiation and tolerance of chemoprevention among women with high-risk breast lesions: the potential of low-dose tamoxifen. Breast Cancer Res Treat. 2022 Jun; 193(2):417-427. PMID: 35378642; PMCID: PMC8978759.
    Citations:    Fields:    Translation:Humans
  33. Song JH, Kantor O, Mittendorf EA, King TA, Minami CA. Race and Site of Care Impact Treatment Delays in Older Women with Non-Metastatic Breast Cancer. Ann Surg Oncol. 2022 Mar 30. PMID: 35353260.
    Citations:    Fields:    
  34. Weiss A, King TA. ASO Author Reflections: Is It Necessary to Routinely Clip and Localize the Biopsy-Proven Malignant Lymph Node? Ann Surg Oncol. 2022 06; 29(6):3772-3773. PMID: 35338407.
    Citations:    Fields:    Translation:Humans
  35. Matar R, Sevilimedu V, Park A, King TA, Pilewskie M. ASO Visual Abstract: Comparison of Outcomes for Classic-Type Lobular Carcinoma In Situ Managed with Surgical Excision After Core Biopsy Versus Observation. Ann Surg Oncol. 2022 Mar; 29(3):1682. PMID: 34997416.
    Citations:    Fields:    
  36. Laws A, Katlin F, Nakhlis F, Chikarmane SA, Schnitt SJ, King TA. ASO Visual Abstract: Atypical Lobular Hyperplasia and Classic Lobular Carcinoma In Situ Can Be Safely Managed Without Surgical Excision. Ann Surg Oncol. 2022 Mar; 29(3):1668-1669. PMID: 34731399.
    Citations:    Fields:    
  37. Weiss A, King C, Grossmith S, Portnow L, Raza S, Nakhlis F, Dominici L, Barbie T, Minami C, Nimbkar S, Rhei E, Mittendorf EA, King TA. How Often Does Retrieval of a Clipped Lymph Node Change Adjuvant Therapy Recommendations? A Prospective, Consecutive, Patient Cohort Study. Ann Surg Oncol. 2022 Jun; 29(6):3764-3771. PMID: 35041097.
    Citations:    Fields:    Translation:Humans
  38. Hersh EH, King TA. De-escalating axillary surgery in early-stage breast cancer. Breast. 2022 Mar; 62 Suppl 1:S43-S49. PMID: 34949533; PMCID: PMC9097808.
    Citations: 1     Fields:    Translation:Humans
  39. Kantor O, Means J, Grossmith S, Dey T, Bellon JR, Mittendorf EA, King TA. ASO Visual Abstract: Optimizing Axillary Management in Clinical T1-2N0 Mastectomy Patients with Positive Sentinel Lymph Nodes. Ann Surg Oncol. 2021 Dec; 28(Suppl 3):702. PMID: 34498159.
    Citations: 2     Fields:    
  40. Kantor O, Wang ML, Bertrand K, Pierce L, Freedman RA, Chavez-MacGregor M, King TA, Mittendorf EA. ASO Visual Abstract: Racial and Socioeconomic Disparities in Breast Cancer Outcomes within the AJCC Pathologic Prognostic Staging System. Ann Surg Oncol. 2021 Dec; 28(Suppl 3):585-586. PMID: 34368929.
    Citations:    Fields:    
  41. Rosenberger LH, Quintana LM, Thomas SM, Nimbkar SN, Hieken TJ, Ludwig KK, Jacobs LK, Miller ME, Gallagher KK, Wong J, Neuman HB, Tseng J, Hassinger TE, King TA, Jakub JW, Bentley RC, Schnitt SJ. ASO Visual Abstract: Limited Reporting of Histopathologic Details in a Multi-Institutional Academic Cohort of Phyllodes Tumors: Time for Standardization. Ann Surg Oncol. 2021 12; 28(Suppl 3):465-466. PMID: 34061280.
    Citations:    Fields:    
  42. Kantor O, King TA, Shak S, Russell CA, Giuliano AE, Hortobagyi GN, Burstein HJ, Winer EP, Dey T, Sparano JA, Mittendorf EA. Expanding Criteria for Prognostic Stage IA in Hormone Receptor-Positive Breast Cancer. J Natl Cancer Inst. 2021 11 29; 113(12):1744-1750. PMID: 34010423; PMCID: PMC8634483.
    Citations: 1     Fields:    
  43. Sella T, Weiss A, Mittendorf EA, King TA, Pilewskie M, Giuliano AE, Metzger-Filho O. Neoadjuvant Endocrine Therapy in Clinical Practice: A Review. JAMA Oncol. 2021 Nov 01; 7(11):1700-1708. PMID: 34499101.
    Citations: 3     Fields:    Translation:Humans
  44. Matar R, Sevilimedu V, Park A, King TA, Pilewskie M. Comparison of Outcomes for Classic-Type Lobular Carcinoma In Situ Managed with Surgical Excision After Core Biopsy Versus Observation. Ann Surg Oncol. 2022 Mar; 29(3):1670-1679. PMID: 34671879.
    Citations: 2     Fields:    Translation:Humans
  45. Dominici L, Hu J, Zheng Y, Kim HJ, King TA, Ruddy KJ, Tamimi RM, Peppercorn J, Schapira L, Borges VF, Come SE, Warner E, Wong JS, Partridge AH, Rosenberg SM. Association of Local Therapy With Quality-of-Life Outcomes in Young Women With Breast Cancer. JAMA Surg. 2021 10 01; 156(10):e213758. PMID: 34468718; PMCID: PMC8411359.
    Citations: 4     Fields:    Translation:Humans
  46. Laws A, Katlin F, Nakhlis F, Chikarmane SA, Schnitt SJ, King TA. Atypical Lobular Hyperplasia and Classic Lobular Carcinoma In Situ Can Be Safely Managed Without Surgical Excision. Ann Surg Oncol. 2022 Mar; 29(3):1660-1667. PMID: 34554341.
    Citations: 2     Fields:    Translation:Humans
  47. Kantor O, Means J, Grossmith S, Dey T, Bellon JR, Mittendorf EA, King TA. Optimizing Axillary Management in Clinical T1-2N0 Mastectomy Patients with Positive Sentinel Lymph Nodes. Ann Surg Oncol. 2022 Feb; 29(2):972-980. PMID: 34467507.
    Citations: 2     Fields:    Translation:Humans
  48. Kantor O, Wang ML, Bertrand K, Pierce L, Freedman RA, Chavez-MacGregor M, King TA, Mittendorf EA. Racial and Socioeconomic Disparities in Breast Cancer Outcomes within the AJCC Pathologic Prognostic Staging System. Ann Surg Oncol. 2022 Jan; 29(1):686-696. PMID: 34331158.
    Citations: 1     Fields:    Translation:Humans
  49. Brackstone M, Baldassarre FG, Perera FE, Cil T, Chavez Mac Gregor M, Dayes IS, Engel J, Horton JK, King TA, Kornecki A, George R, SenGupta SK, Spears PA, Eisen AF. Management of the Axilla in Early-Stage Breast Cancer: Ontario Health (Cancer Care Ontario) and ASCO Guideline. J Clin Oncol. 2021 09 20; 39(27):3056-3082. PMID: 34279999.
    Citations: 10     Fields:    Translation:Humans
  50. Rosenberger LH, Quintana LM, Thomas SM, Nimbkar SN, Hieken TJ, Ludwig KK, Jacobs LK, Miller ME, Gallagher KK, Wong J, Neuman HB, Tseng J, Hassinger TE, King TA, Jakub JW, Bentley RC, Schnitt SJ. Limited Reporting of Histopathologic Details in a Multi-Institutional Academic Cohort of Phyllodes Tumors: Time for Standardization. Ann Surg Oncol. 2021 Nov; 28(12):7404-7409. PMID: 33990927; PMCID: PMC8530846.
    Citations: 1     Fields:    Translation:HumansCells
  51. Kantor O, Laws A, Pastorello RG, King C, Wong S, Dey T, Schnitt S, King TA, Mittendorf EA. Comparison of Breast Cancer Staging Systems After Neoadjuvant Chemotherapy. Ann Surg Oncol. 2021 Nov; 28(12):7347-7355. PMID: 33956276.
    Citations: 2     Fields:    Translation:Humans
  52. Filho OM, Viale G, Stein S, Trippa L, Yardley DA, Mayer IA, Abramson VG, Arteaga CL, Spring LM, Waks AG, Wrabel E, DeMeo MK, Bardia A, Dell'Orto P, Russo L, King TA, Polyak K, Michor F, Winer EP, Krop IE. Impact of HER2 Heterogeneity on Treatment Response of Early-Stage HER2-Positive Breast Cancer: Phase II Neoadjuvant Clinical Trial of T-DM1 Combined with Pertuzumab. Cancer Discov. 2021 10; 11(10):2474-2487. PMID: 33941592; PMCID: PMC8598376.
    Citations: 9     Fields:    Translation:HumansCTClinical Trials
  53. Kuijer A, Dominici LS, Rosenberg SM, Hu J, Gelber S, Di Lascio S, Wong JS, Ruddy KJ, Tamimi RM, Schapira L, Borges VF, Come SE, Sprunck-Harrild K, Partridge AH, King TA. Arm Morbidity After Local Therapy for Young Breast Cancer Patients. Ann Surg Oncol. 2021 Oct; 28(11):6071-6082. PMID: 33881656.
    Citations: 1     Fields:    Translation:Humans
  54. Freedman RA, Sedrak MS, Bellon JR, Block CC, Lin NU, King TA, Minami C, VanderWalde N, Jolly TA, Muss HB, Winer EP. Weathering the Storm: Managing Older Adults With Breast Cancer Amid COVID-19 and Beyond. J Natl Cancer Inst. 2021 04 06; 113(4):355-359. PMID: 32449757.
    Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
  55. Kantor O, King TA. ASO Author Reflections: Tailoring Axillary Surgery After Neoadjuvant Endocrine Therapy for Breast Cancer. Ann Surg Oncol. 2021 Mar; 28(3):1368-1369. PMID: 33389297.
    Citations:    Fields:    Translation:Humans
  56. Kim HJ, Dominici L, Rosenberg SM, Zheng Y, Pak LM, Poorvu PD, Ruddy KJ, Tamimi R, Schapira L, Come SE, Peppercorn J, Borges VF, Warner E, Vardeh H, Collins LC, Gaither R, King TA, Partridge AH. Surgical Treatment After Neoadjuvant Systemic Therapy in Young Women With Breast Cancer: Results From a Prospective Cohort Study. Ann Surg. 2022 07 01; 276(1):173-179. PMID: 33378304.
    Citations: 6     Fields:    Translation:Humans
  57. Rosenberger LH, Thomas SM, Nimbkar SN, Hieken TJ, Ludwig KK, Jacobs LK, Miller ME, Gallagher KK, Wong J, Neuman HB, Tseng J, Hassinger TE, King TA, Jakub JW. Contemporary Multi-Institutional Cohort of 550 Cases of Phyllodes Tumors (2007-2017) Demonstrates a Need for More Individualized Margin Guidelines. J Clin Oncol. 2021 01 20; 39(3):178-189. PMID: 33301374; PMCID: PMC8462612.
    Citations: 5     Fields:    Translation:Humans
  58. Pak LM, Gaither R, Rosenberg SM, Ruddy KJ, Tamimi RM, Peppercorn J, Schapira L, Borges VF, Come SE, Warner E, Snow C, Collins LC, King TA, Partridge AH. Tumor phenotype and concordance in synchronous bilateral breast cancer in young women. Breast Cancer Res Treat. 2021 Apr; 186(3):815-821. PMID: 33242164.
    Citations:    Fields:    Translation:Humans
  59. Pastorello RG, Laws A, Grossmith S, King C, McGrath M, Mittendorf EA, King TA, Schnitt SJ. Clinico-pathologic predictors of patterns of residual disease following neoadjuvant chemotherapy for breast cancer. Mod Pathol. 2021 05; 34(5):875-882. PMID: 33219297.
    Citations: 2     Fields:    Translation:Humans
  60. Denduluri N, Somerfield MR, Chavez-MacGregor M, Comander AH, Dayao Z, Eisen A, Freedman RA, Gopalakrishnan R, Graff SL, Hassett MJ, King TA, Lyman GH, Maupin GR, Nunes R, Perkins CL, Telli ML, Trudeau ME, Wolff AC, Giordano SH. Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Guideline Update. J Clin Oncol. 2021 02 20; 39(6):685-693. PMID: 33079579.
    Citations: 17     Fields:    Translation:Humans
  61. Nakhlis F, Baker GM, Pilewskie M, Gelman R, Calvillo KZ, Ludwig K, McAuliffe PF, Willey S, Rosenberger LH, Parker C, Gallagher K, Jacobs L, Feldman S, Lange P, DeSantis SD, Schnitt SJ, King TA. The Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In Situ in Patients with Intraductal Papilloma without Atypia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 034). Ann Surg Oncol. 2021 May; 28(5):2573-2578. PMID: 33047246.
    Citations: 3     Fields:    Translation:Humans
  62. Weiss A, Mittendorf EA, King TA. Strategies to Optimize Axillary Surgery in Patients With Breast Cancer Receiving Neoadjuvant Endocrine Therapy. Oncology (Williston Park). 2020 Oct 09; 34(10):397-404. PMID: 33058105.
    Citations:    Fields:    Translation:Humans
  63. Bellon JR, Burstein HJ, Frank ES, Mittendorf EA, King TA. Multidisciplinary considerations in the treatment of triple-negative breast cancer. CA Cancer J Clin. 2020 11; 70(6):432-442. PMID: 32986241.
    Citations: 2     Fields:    Translation:Humans
  64. Losk K, Freedman RA, Laws A, Kantor O, Mittendorf EA, Tan-Wasielewski Z, Trippa L, Lin NU, Winer EP, King TA. Oncotype DX testing in node-positive breast cancer strongly impacts chemotherapy use at a comprehensive cancer center. Breast Cancer Res Treat. 2021 Jan; 185(1):215-227. PMID: 32939592.
    Citations: 5     Fields:    Translation:Humans
  65. Kantor O, Wakeman M, Weiss A, Wong S, Laws A, Grossmith S, Mittendorf EA, King TA. Axillary Management After Neoadjuvant Endocrine Therapy for Hormone Receptor-Positive Breast Cancer. Ann Surg Oncol. 2021 Mar; 28(3):1358-1367. PMID: 32869154.
    Citations: 6     Fields:    Translation:Humans
  66. King TA. Reply to Comment on Margins in Breast-Conserving Surgery After Neoadjuvant Therapy. Ann Surg Oncol. 2021 07; 28(7):4053. PMID: 32864729.
    Citations:    Fields:    Translation:Humans
  67. Kantor O, Wong S, Weiss A, Metzger O, Mittendorf EA, King TA. Prognostic significance of residual nodal disease after neoadjuvant endocrine therapy for hormone receptor-positive breast cancer. NPJ Breast Cancer. 2020 Aug 13; 6(1):35. PMID: 33579920.
    Citations:    
  68. Kantor O, Wong S, Weiss A, Metzger O, Mittendorf EA, King TA. Prognostic significance of residual nodal disease after neoadjuvant endocrine therapy for hormone receptor-positive breast cancer. NPJ Breast Cancer. 2020; 6:35. PMID: 32821803.
    Citations: 8     
  69. Minami CA, Kantor O, Weiss A, Nakhlis F, King TA, Mittendorf EA. Association Between Time to Operation and Pathologic Stage in Ductal Carcinoma in Situ and Early-Stage Hormone Receptor-Positive Breast Cancer. J Am Coll Surg. 2020 10; 231(4):434-447.e2. PMID: 32771654; PMCID: PMC7409804.
    Citations: 11     Fields:    Translation:HumansCellsPHPublic Health
  70. Minami CA, King TA, Mittendorf EA. Patient preferences for locoregional therapy in early-stage breast cancer. Breast Cancer Res Treat. 2020 Sep; 183(2):291-309. PMID: 32691377.
    Citations: 1     Fields:    Translation:Humans
  71. Weiss A, King TA, Mittendorf EA. The Landmark Series: Neoadjuvant Endocrine Therapy for Breast Cancer. Ann Surg Oncol. 2020 Sep; 27(9):3393-3401. PMID: 32591951.
    Citations: 2     Fields:    Translation:Humans
  72. Mittendorf EA, Bellon JR, King TA. Regional Nodal Management in Patients With Clinically Node-Negative Breast Cancer Undergoing Upfront Surgery. J Clin Oncol. 2020 07 10; 38(20):2273-2280. PMID: 32442075.
    Citations:    Fields:    Translation:Humans
  73. Ho AY, Wright JL, Blitzblau RC, Mutter RW, Duda DG, Norton L, Bardia A, Spring L, Isakoff SJ, Chen JH, Grassberger C, Bellon JR, Beriwal S, Khan AJ, Speers C, Dunn SA, Thompson A, Santa-Maria CA, Krop IE, Mittendorf E, King TA, Gupta GP. Optimizing Radiation Therapy to Boost Systemic Immune Responses in Breast Cancer: A Critical Review for Breast Radiation Oncologists. Int J Radiat Oncol Biol Phys. 2020 09 01; 108(1):227-241. PMID: 32417409.
    Citations: 6     Fields:    Translation:Humans
  74. Woodward WA, Barlow WE, Jagsi R, Buchholz TA, Shak S, Baehner F, Whelan TJ, Davidson NE, Ingle JN, King TA, Ravdin PM, Osborne CK, Tripathy D, Livingston RB, Gralow JR, Hortobagyi GN, Hayes DF, Albain KS. Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer. JAMA Oncol. 2020 04 01; 6(4):505-511. PMID: 31917424.
    Citations: 11     Fields:    Translation:HumansCTClinical Trials
  75. Schnitt SJ, Brogi E, Chen YY, King TA, Lakhani SR. American Registry of Pathology Expert Opinions: The Spectrum of Lobular Carcinoma in Situ: Diagnostic Features and Clinical Implications. Ann Diagn Pathol. 2020 Apr; 45:151481. PMID: 32120324.
    Citations: 3     Fields:    Translation:Humans
  76. Fayanju OM, Ren Y, Greenup RA, Plichta JK, Rosenberger LH, Force J, Suneja G, Devi GR, King TA, Nakhlis F, Hyslop T, Hwang ES. Extent of axillary surgery in inflammatory breast cancer: a survival analysis of 3500 patients. Breast Cancer Res Treat. 2020 Feb; 180(1):207-217. PMID: 31960171.
    Citations: 5     Fields:    Translation:Humans
  77. Heng YJ, Hankinson SE, Wang J, Alexandrov LB, Ambrosone CB, de Andrade VP, Brufsky AM, Couch FJ, King TA, Modugno F, Vachon CM, Eliassen AH, Tamimi RM, Kraft P. The Association of Modifiable Breast Cancer Risk Factors and Somatic Genomic Alterations in Breast Tumors: The Cancer Genome Atlas Network. Cancer Epidemiol Biomarkers Prev. 2020 03; 29(3):599-605. PMID: 31932411.
    Citations: 2     Fields:    Translation:Humans
  78. Harrison BT, Nakhlis F, Dillon DA, Soong TR, Garcia EP, Schnitt SJ, King TA. Genomic profiling of pleomorphic and florid lobular carcinoma in situ reveals highly recurrent ERBB2 and ERRB3 alterations. Mod Pathol. 2020 07; 33(7):1287-1297. PMID: 31932682.
    Citations: 7     Fields:    Translation:Humans
  79. Kantor O, Niu J, Zhao H, Giordano SH, Hunt KK, King TA, Mittendorf EA, Chavez-MacGregor M. Comparative Analysis of Proposed Strategies for Incorporating Biologic Factors into Breast Cancer Staging. Ann Surg Oncol. 2020 Jul; 27(7):2229-2237. PMID: 31916091.
    Citations: 4     Fields:    Translation:Humans
  80. Minami CA, Zabor EC, Gilbert E, Newman A, Park A, Jochelson MS, King TA, Pilewskie ML. Do Body Mass Index and Breast Density Impact Cancer Risk Among Women with Lobular Carcinoma In Situ? Ann Surg Oncol. 2020 Jun; 27(6):1844-1851. PMID: 31898097.
    Citations: 1     Fields:    Translation:Humans
  81. Valero MG, King TA, Pilewskie ML. ASO Author Reflections: Breast Cancer Risk Assessment in Women with LCIS-More Work Is Needed. Ann Surg Oncol. 2020 Mar; 27(3):741-742. PMID: 31863418.
    Citations:    Fields:    Translation:Humans
  82. Lagendijk M, Mittendorf E, King TA, Gibbons C, Pusic A, Dominici LS. Incorporating Patient-Reported Outcome Measures into Breast Surgical Oncology: Advancing Toward Value-Based Care. Oncologist. 2020 05; 25(5):384-390. PMID: 31848315; PMCID: PMC7216450.
    Citations: 1     Fields:    Translation:Humans
  83. Yi M, Lin H, Bedrosian I, Shen Y, Hunt KK, Chavez-MacGregor M, King TA, Mittendorf EA. Staging for Breast Cancer Patients Receiving Neoadjuvant Chemotherapy: Utility of Incorporating Biologic Factors. Ann Surg Oncol. 2020 Feb; 27(2):359-366. PMID: 31667721.
    Citations:    Fields:    Translation:Humans
  84. Berry DL, Blonquist TM, Halpenny B, Hong F, Morrison-Ma SC, McCullough MC, Carelli K, Dominici LS, King TA. The Jacki Jacket after mastectomy with reconstruction: a randomized pilot study. Breast Cancer Res Treat. 2020 Jan; 179(2):377-385. PMID: 31612292.
    Citations: 1     Fields:    Translation:Humans
  85. Weiss A, Wong S, Golshan M, Freedman RA, Metzger O, Bellon J, Mittendorf EA, King TA. Patterns of Axillary Management in Stages 2 and 3 Hormone Receptor-Positive Breast Cancer by Initial Treatment Approach. Ann Surg Oncol. 2019 Dec; 26(13):4326-4336. PMID: 31562601.
    Citations: 8     Fields:    Translation:Humans
  86. Valero MG, Zabor EC, Park A, Gilbert E, Newman A, King TA, Pilewskie ML. The Tyrer-Cuzick Model Inaccurately Predicts Invasive Breast Cancer Risk in Women With LCIS. Ann Surg Oncol. 2020 Mar; 27(3):736-740. PMID: 31559544.
    Citations: 2     Fields:    Translation:Humans
  87. Nakhlis F, Regan MM, Chun YS, Dominici LS, Caterson S, Bellon JR, Warren L, Yeh ED, Jacene HA, King TA, Overmoyer B. Patterns of breast reconstruction in patients diagnosed with inflammatory breast cancer: The Dana-Farber Cancer Institute's Inflammatory Breast Cancer Program experience. Breast J. 2020 03; 26(3):384-390. PMID: 31448540.
    Citations: 3     Fields:    Translation:Humans
  88. Mamtani A, Nakhlis F, Downs-Canner S, Zabor EC, Morrow M, King TA, Van Zee KJ. Impact of Age on Locoregional and Distant Recurrence After Mastectomy for Ductal Carcinoma In Situ With or Without Microinvasion. Ann Surg Oncol. 2019 Dec; 26(13):4264-4271. PMID: 31440931.
    Citations: 7     Fields:    Translation:Humans
  89. Wong SM, Weiss A, Mittendorf EA, King TA, Golshan M. Surgical Management of the Axilla in Clinically Node-Positive Patients Receiving Neoadjuvant Chemotherapy: A National Cancer Database Analysis. Ann Surg Oncol. 2019 Oct; 26(11):3517-3525. PMID: 31342389.
    Citations: 8     Fields:    Translation:Humans
  90. Baker GM, King TA, Schnitt SJ. Evaluation of Breast and Axillary Lymph Node Specimens in Breast Cancer Patients Treated With Neoadjuvant Systemic Therapy. Adv Anat Pathol. 2019 Jul; 26(4):221-234. PMID: 31149907.
    Citations: 5     Fields:    Translation:Humans
  91. Wong SM, Almana N, Choi J, Hu J, Gagnon H, Natsuhara K, Shen AH, DeSantis S, Dominici L, Golshan M, Weiss A, Bellon J, Mittendorf EA, King TA. Prognostic Significance of Residual Axillary Nodal Micrometastases and Isolated Tumor Cells After Neoadjuvant Chemotherapy for Breast Cancer. Ann Surg Oncol. 2019 Oct; 26(11):3502-3509. PMID: 31228134.
    Citations: 13     Fields:    Translation:HumansCells
  92. Laws A, Hughes ME, Hu J, Barry WT, Dominici L, Nakhlis F, Barbie T, Duggan M, Weiss A, Rhei E, Carter K, Nimbkar S, Schnitt SJ, King TA. Impact of Residual Nodal Disease Burden on Technical Outcomes of Sentinel Lymph Node Biopsy for Node-Positive (cN1) Breast Cancer Patients Treated with Neoadjuvant Chemotherapy. Ann Surg Oncol. 2019 Nov; 26(12):3846-3855. PMID: 31222687.
    Citations: 3     Fields:    Translation:Humans
  93. Sinn BV, Fu C, Lau R, Litton J, Tsai TH, Murthy R, Tam A, Andreopoulou E, Gong Y, Murthy R, Gould R, Zhang Y, King TA, Viale A, Andrade V, Giri D, Salgado R, Laios I, Sotiriou C, Marginean EC, Kwiatkowski DN, Layman RM, Booser D, Hatzis C, Vicente Valero V, Fraser Symmans W. SETER/PR: a robust 18-gene predictor for sensitivity to endocrine therapy for metastatic breast cancer. NPJ Breast Cancer. 2019; 5:16. PMID: 31231679; PMCID: PMC6542807.
    Citations: 16     
  94. Mittendorf EA, King TA. Routine Use of Oncotype DX Recurrence Score Testing in Node-Positive Hormone Receptor-Positive HER2-Negative Breast Cancer: The Time Has Come. Ann Surg Oncol. 2019 May; 26(5):1173-1175. PMID: 30798446.
    Citations: 5     Fields:    Translation:Humans
  95. Nik-Zainal S, Davies H, Staaf J, Ramakrishna M, Glodzik D, Zou X, Martincorena I, Alexandrov LB, Martin S, Wedge DC, Van Loo P, Ju YS, Smid M, Brinkman AB, Morganella S, Aure MR, Lingjærde OC, Langerød A, Ringnér M, Ahn SM, Boyault S, Brock JE, Broeks A, Butler A, Desmedt C, Dirix L, Dronov S, Fatima A, Foekens JA, Gerstung M, Hooijer GKJ, Jang SJ, Jones DR, Kim HY, King TA, Krishnamurthy S, Lee HJ, Lee JY, Li Y, McLaren S, Menzies A, Mustonen V, O'Meara S, Pauporté I, Pivot X, Purdie CA, Raine K, Ramakrishnan K, Rodríguez-González FG, Romieu G, Sieuwerts AM, Simpson PT, Shepherd R, Stebbings L, Stefansson OA, Teague J, Tommasi S, Treilleux I, Van den Eynden GG, Vermeulen P, Vincent-Salomon A, Yates L, Caldas C, Van't Veer L, Tutt A, Knappskog S, Tan BKT, Jonkers J, Borg Å, Ueno NT, Sotiriou C, Viari A, Futreal PA, Campbell PJ, Span PN, Van Laere S, Lakhani SR, Eyfjord JE, Thompson AM, Birney E, Stunnenberg HG, van de Vijver MJ, Martens JWM, Børresen-Dale AL, Richardson AL, Kong G, Thomas G, Stratton MR. Author Correction: Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature. 2019 02; 566(7742):E1. PMID: 30659290.
    Citations: 6     Fields:    
  96. Weiss A, Grossmith S, Cutts D, Mikami SA, Suskin JA, Graichen MK, Rojas NA, Pace LE, Joyce E, Rhei E, Scheib R, Bychkovsky B, Garber JE, Morganstern D, King TA. Customized breast cancer risk assessment in an ambulatory clinic: a portal for identifying women at risk. Breast Cancer Res Treat. 2019 May; 175(1):229-237. PMID: 30666540.
    Citations: 3     Fields:    Translation:HumansPHPublic Health
  97. Coopey SB, Kartal K, Li C, Yala A, Barzilay R, Faulkner HR, King TA, Acevedo F, Garber JE, Guidi AJ, Hughes KS. Atypical ductal hyperplasia in men with gynecomastia: what is their breast cancer risk? Breast Cancer Res Treat. 2019 May; 175(1):1-4. PMID: 30666539.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  98. Punglia RS, Bifolck K, Golshan M, Lehman C, Collins L, Polyak K, Mittendorf E, Garber J, Hwang SE, Schnitt SJ, Partridge AH, King TA. Epidemiology, Biology, Treatment, and Prevention of Ductal Carcinoma In Situ (DCIS). JNCI Cancer Spectr. 2018 Nov; 2(4):pky063. PMID: 30627695.
    Citations: 6     Fields:    
  99. Heng YJ, Wang J, Ahearn TU, Brown SB, Zhang X, Ambrosone CB, de Andrade VP, Brufsky AM, Couch FJ, King TA, Modugno F, Vachon CM, DuPre NC, Garcia-Closas M, Troester MA, Hunter DJ, Eliassen AH, Tamimi RM, Hankinson SE, Beck AH. Molecular mechanisms linking high body mass index to breast cancer etiology in post-menopausal breast tumor and tumor-adjacent tissues. Breast Cancer Res Treat. 2019 Feb; 173(3):667-677. PMID: 30387004; PMCID: PMC6391202.
    Citations: 14     Fields:    Translation:HumansCellsPHPublic Health
  100. Nakhlis F, Harrison BT, Giess CS, Lester SC, Hughes KS, Coopey SB, King TA. Evaluating the Rate of Upgrade to Invasive Breast Cancer and/or Ductal Carcinoma In Situ Following a Core Biopsy Diagnosis of Non-classic Lobular Carcinoma In Situ. Ann Surg Oncol. 2019 Jan; 26(1):55-61. PMID: 30362065.
    Citations: 9     Fields:    Translation:Humans
  101. Lee JY, Schizas M, Geyer FC, Selenica P, Piscuoglio S, Sakr RA, Ng CKY, Carniello JVS, Towers R, Giri DD, de Andrade VP, Papanastasiou AD, Viale A, Harris RS, Solit DB, Weigelt B, Reis-Filho JS, King TA. Lobular Carcinomas In Situ Display Intralesion Genetic Heterogeneity and Clonal Evolution in the Progression to Invasive Lobular Carcinoma. Clin Cancer Res. 2019 01 15; 25(2):674-686. PMID: 30185420; PMCID: PMC6726436.
    Citations: 23     Fields:    Translation:Humans
  102. Laws A, Anderson K, Hu J, McLean K, Novak L, Dominici LS, Nakhlis F, Carty M, Caterson S, Chun Y, Duggan M, Barry W, Connell N, Golshan M, King TA. Implementation of a Venous Thromboembolism Prophylaxis Protocol Using the Caprini Risk Assessment Model in Patients Undergoing Mastectomy. Ann Surg Oncol. 2018 Nov; 25(12):3548-3555. PMID: 30128903.
    Citations: 5     Fields:    Translation:Humans
  103. Natsuhara KH, Losk K, King TA, Lin NU, Camuso K, Golshan M, Pochebit S, Brock JE, Bunnell CA, Freedman RA. Impact of Genomic Assay Testing and Clinical Factors on Chemotherapy Use After Implementation of Standardized Testing Criteria. Oncologist. 2019 05; 24(5):595-602. PMID: 30076279.
    Citations: 6     Fields:    Translation:Humans
  104. Spivey TL, Gutowski ED, Zinboonyahgoon N, King TA, Dominici L, Edwards RR, Golshan M, Schreiber KL. Chronic Pain After Breast Surgery: A Prospective, Observational Study. Ann Surg Oncol. 2018 Oct; 25(10):2917-2924. PMID: 30014456.
    Citations: 19     Fields:    Translation:Humans
  105. Grossmith S, Nguyen A, Hu J, Plichta JK, Nakhlis F, Cutone L, Dominici L, Golshan M, Duggan M, Carter K, Rhei E, Barbie T, Calvillo K, Nimbkar S, Bellon J, Wong J, Punglia R, Barry W, King TA. Multidisciplinary Management of the Axilla in Patients with cT1-T2 N0 Breast Cancer Undergoing Primary Mastectomy: Results from a Prospective Single-Institution Series. Ann Surg Oncol. 2018 Nov; 25(12):3527-3534. PMID: 29868979.
    Citations: 5     Fields:    Translation:HumansCTClinical Trials
  106. Moossdorff M, Nakhlis F, Hu J, Barry WT, Losk K, Haskett C, Smidt ML, King TA. The Potential Impact of AMAROS on the Management of the Axilla in Patients with Clinical T1-2N0 Breast Cancer Undergoing Primary Total Mastectomy. Ann Surg Oncol. 2018 Sep; 25(9):2612-2619. PMID: 29855827.
    Citations: 5     Fields:    Translation:Humans
  107. Sirinian C, Papanastasiou AD, Schizas M, Spella M, Stathopoulos GT, Repanti M, Zarkadis IK, King TA, Kalofonos HP. RANK-c attenuates aggressive properties of ER-negative breast cancer by inhibiting NF-?B activation and EGFR signaling. Oncogene. 2018 09; 37(37):5101-5114. PMID: 29844572.
    Citations: 11     Fields:    Translation:HumansAnimalsCells
  108. Denduluri N, Chavez-MacGregor M, Telli ML, Eisen A, Graff SL, Hassett MJ, Holloway JN, Hurria A, King TA, Lyman GH, Partridge AH, Somerfield MR, Trudeau ME, Wolff AC, Giordano SH. Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Clinical Practice Guideline Focused Update. J Clin Oncol. 2018 08 10; 36(23):2433-2443. PMID: 29787356.
    Citations: 43     Fields:    Translation:Humans
  109. Weiss A, King TA, Hunt KK, Mittendorf EA. Incorporating Biologic Factors into the American Joint Committee on Cancer Breast Cancer Staging System: Review of the Supporting Evidence. Surg Clin North Am. 2018 Aug; 98(4):687-702. PMID: 30005768.
    Citations: 11     Fields:    Translation:Humans
  110. Fairweather M, Jiang W, Keating NL, Freedman RA, King TA, Nakhlis F. Morbidity of local therapy for locally advanced metastatic breast cancer: an analysis of the Surveillance, Epidemiology, and End Results (SEER)-Medicare Registry. Breast Cancer Res Treat. 2018 Jun; 169(2):287-293. PMID: 29374851.
    Citations: 1     Fields:    Translation:Humans
  111. Mamtani A, King TA. Lobular Breast Cancer: Different Disease, Different Algorithms? Surg Oncol Clin N Am. 2018 01; 27(1):81-94. PMID: 29132567.
    Citations: 11     Fields:    Translation:Humans
  112. Leiter A, Bickell NA, LeRoith D, Nayak A, Feldman SM, Friedman NB, Estabrook A, King TA, Fei K, Franco R, Gallagher EJ. Statin Use and Breast Cancer Prognosis in Black and White Women. Horm Cancer. 2018 02; 9(1):55-61. PMID: 29052171; PMCID: PMC5873288.
    Citations: 2     Fields:    Translation:Humans
  113. Dominici LS, Sineshaw HM, Jemal A, Lin CC, King TA, Freedman RA. Patterns of axillary evaluation in older patients with breast cancer and associations with adjuvant therapy receipt. Breast Cancer Res Treat. 2018 01; 167(2):555-566. PMID: 28990127.
    Citations: 6     Fields:    Translation:Humans
  114. Begg CB, Ostrovnaya I, Geyer FC, Papanastasiou AD, Ng CKY, Sakr RA, Bernstein JL, Burke KA, King TA, Piscuoglio S, Mauguen A, Orlow I, Weigelt B, Seshan VE, Morrow M, Reis-Filho JS. Contralateral breast cancers: Independent cancers or metastases? Int J Cancer. 2018 01 15; 142(2):347-356. PMID: 28921573; PMCID: PMC5749409.
    Citations: 17     Fields:    Translation:Humans
  115. Wang J, Heng YJ, Eliassen AH, Tamimi RM, Hazra A, Carey VJ, Ambrosone CB, de Andrade VP, Brufsky A, Couch FJ, King TA, Modugno F, Vachon CM, Hunter DJ, Beck AH, Hankinson SE. Alcohol consumption and breast tumor gene expression. Breast Cancer Res. 2017 Sep 12; 19(1):108. PMID: 28899409; PMCID: PMC5596493.
    Citations: 15     Fields:    Translation:Humans
  116. Losk K, Freedman RA, Lin NU, Golshan M, Pochebit SM, Lester SC, Natsuhara K, Camuso K, King TA, Bunnell CA. Implementation of Surgeon-Initiated Gene Expression Profile Testing (Onco type DX) Among Patients With Early-Stage Breast Cancer to Reduce Delays in Chemotherapy Initiation. J Oncol Pract. 2017 09; 13(9):e815-e820. PMID: 28858535.
    Citations: 6     Fields:    Translation:Humans
  117. Mamtani A, King TA. Targeted Therapy and Local Control: The Dynamic Duo. Ann Surg Oncol. 2017 Oct; 24(11):3110-3112. PMID: 28748442.
    Citations:    Fields:    Translation:Humans
  118. Kuijer A, King TA. Age, molecular subtypes and local therapy decision-making. Breast. 2017 Aug; 34 Suppl 1:S70-S77. PMID: 28666919.
    Citations: 1     Fields:    Translation:Humans
  119. De Brot M, Koslow Mautner S, Muhsen S, Andrade VP, Mamtani A, Murray M, Giri D, Sakr RA, Brogi E, King TA. Pleomorphic lobular carcinoma in situ of the breast: a single institution experience with clinical follow-up and centralized pathology review. Breast Cancer Res Treat. 2017 Sep; 165(2):411-420. PMID: 28612228; PMCID: PMC5634524.
    Citations: 10     Fields:    Translation:Humans
  120. Mutter RW, Riaz N, Ng CK, Delsite R, Piscuoglio S, Edelweiss M, Martelotto LG, Sakr RA, King TA, Giri DD, Drobnjak M, Brogi E, Bindra R, Bernheim G, Lim RS, Blecua P, Desrichard A, Higginson D, Towers R, Jiang R, Lee W, Weigelt B, Reis-Filho JS, Powell SN. Bi-allelic alterations in DNA repair genes underpin homologous recombination DNA repair defects in breast cancer. J Pathol. 2017 06; 242(2):165-177. PMID: 28299801; PMCID: PMC5516531.
    Citations: 26     Fields:    Translation:HumansCells
  121. Davies H, Glodzik D, Morganella S, Yates LR, Staaf J, Zou X, Ramakrishna M, Martin S, Boyault S, Sieuwerts AM, Simpson PT, King TA, Raine K, Eyfjord JE, Kong G, Borg Å, Birney E, Stunnenberg HG, van de Vijver MJ, Børresen-Dale AL, Martens JW, Span PN, Lakhani SR, Vincent-Salomon A, Sotiriou C, Tutt A, Thompson AM, Van Laere S, Richardson AL, Viari A, Campbell PJ, Stratton MR, Nik-Zainal S. HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures. Nat Med. 2017 Apr; 23(4):517-525. PMID: 28288110; PMCID: PMC5833945.
    Citations: 292     Fields:    Translation:Humans
  122. Martelotto LG, Baslan T, Kendall J, Geyer FC, Burke KA, Spraggon L, Piscuoglio S, Chadalavada K, Nanjangud G, Ng CK, Moody P, D'Italia S, Rodgers L, Cox H, da Cruz Paula A, Stepansky A, Schizas M, Wen HY, King TA, Norton L, Weigelt B, Hicks JB, Reis-Filho JS. Whole-genome single-cell copy number profiling from formalin-fixed paraffin-embedded samples. Nat Med. 2017 Mar; 23(3):376-385. PMID: 28165479; PMCID: PMC5608257.
    Citations: 55     Fields:    Translation:HumansCells
  123. Denduluri N, Somerfield MR, Eisen A, Holloway JN, Hurria A, King TA, Lyman GH, Partridge AH, Telli ML, Trudeau ME, Wolff AC. Reply to L. Del Mastro and A. Prat. J Clin Oncol. 2017 04 01; 35(10):1139. PMID: 28095161.
    Citations:    Fields:    Translation:Humans
  124. Dominici LS, Morrow M, Mittendorf E, Bellon J, King TA. Trends and controversies in multidisciplinary care of the patient with breast cancer. Curr Probl Surg. 2016 Dec; 53(12):559-595. PMID: 28160790; PMCID: PMC5298793.
    Citations: 3     Fields:    Translation:Humans
  125. Radosa JC, Eaton A, Stempel M, Khander A, Liedtke C, Solomayer EF, Karsten M, Pilewskie M, Morrow M, King TA. Evaluation of Local and Distant Recurrence Patterns in Patients with Triple-Negative Breast Cancer According to Age. Ann Surg Oncol. 2017 Mar; 24(3):698-704. PMID: 27783163; PMCID: PMC5408739.
    Citations: 13     Fields:    Translation:Humans
  126. Begg CB, Ostrovnaya I, Carniello JV, Sakr RA, Giri D, Towers R, Schizas M, De Brot M, Andrade VP, Mauguen A, Seshan VE, King TA. Clonal relationships between lobular carcinoma in situ and other breast malignancies. Breast Cancer Res. 2016 06 23; 18(1):66. PMID: 27334989; PMCID: PMC4918003.
    Citations: 15     Fields:    Translation:Humans
  127. Di Meglio A, Freedman RA, Lin NU, Barry WT, Metzger-Filho O, Keating NL, King TA, Sertoli MR, Boccardo F, Winer EP, Vaz-Luis I. Time trends in incidence rates and survival of newly diagnosed stage IV breast cancer by tumor histology: a population-based analysis. Breast Cancer Res Treat. 2016 06; 157(3):587-96. PMID: 27271765.
    Citations: 15     Fields:    Translation:Humans
  128. Rosenberg SM, King TA. Contralateral prophylactic mastectomy and quality of life: answering the unanswered questions? Gland Surg. 2016 Jun; 5(3):261-2. PMID: 27294031; PMCID: PMC4884699.
    Citations: 3     
  129. Mamtani A, Barrio AV, King TA, Van Zee KJ, Plitas G, Pilewskie M, El-Tamer M, Gemignani ML, Heerdt AS, Sclafani LM, Sacchini V, Cody HS, Patil S, Morrow M. How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective Study. Ann Surg Oncol. 2016 10; 23(11):3467-3474. PMID: 27160528; PMCID: PMC5070651.
    Citations: 80     Fields:    Translation:Humans
  130. Nik-Zainal S, Davies H, Staaf J, Ramakrishna M, Glodzik D, Zou X, Martincorena I, Alexandrov LB, Martin S, Wedge DC, Van Loo P, Ju YS, Smid M, Brinkman AB, Morganella S, Aure MR, Lingjærde OC, Langerød A, Ringnér M, Ahn SM, Boyault S, Brock JE, Broeks A, Butler A, Desmedt C, Dirix L, Dronov S, Fatima A, Foekens JA, Gerstung M, Hooijer GK, Jang SJ, Jones DR, Kim HY, King TA, Krishnamurthy S, Lee HJ, Lee JY, Li Y, McLaren S, Menzies A, Mustonen V, O'Meara S, Pauporté I, Pivot X, Purdie CA, Raine K, Ramakrishnan K, Rodríguez-González FG, Romieu G, Sieuwerts AM, Simpson PT, Shepherd R, Stebbings L, Stefansson OA, Teague J, Tommasi S, Treilleux I, Van den Eynden GG, Vermeulen P, Vincent-Salomon A, Yates L, Caldas C, van't Veer L, Tutt A, Knappskog S, Tan BK, Jonkers J, Borg Å, Ueno NT, Sotiriou C, Viari A, Futreal PA, Campbell PJ, Span PN, Van Laere S, Lakhani SR, Eyfjord JE, Thompson AM, Birney E, Stunnenberg HG, van de Vijver MJ, Martens JW, Børresen-Dale AL, Richardson AL, Kong G, Thomas G, Stratton MR. Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature. 2016 06 02; 534(7605):47-54. PMID: 27135926; PMCID: PMC4910866.
    Citations: 823     Fields:    Translation:HumansCells
  131. Denduluri N, Somerfield MR, Eisen A, Holloway JN, Hurria A, King TA, Lyman GH, Partridge AH, Telli ML, Trudeau ME, Wolff AC. Selection of Optimal Adjuvant Chemotherapy Regimens for Human Epidermal Growth Factor Receptor 2 (HER2) -Negative and Adjuvant Targeted Therapy for HER2-Positive Breast Cancers: An American Society of Clinical Oncology Guideline Adaptation of the Cancer Care Ontario Clinical Practice Guideline. J Clin Oncol. 2016 07 10; 34(20):2416-27. PMID: 27091714.
    Citations: 37     Fields:    Translation:Humans
  132. King TA, Lyman JP, Gonen M, Voci A, De Brot M, Boafo C, Sing AP, Hwang ES, Alvarado MD, Liu MC, Boughey JC, McGuire KP, Van Poznak CH, Jacobs LK, Meszoely IM, Krontiras H, Babiera GV, Norton L, Morrow M, Hudis CA. Prognostic Impact of 21-Gene Recurrence Score in Patients With Stage IV Breast Cancer: TBCRC 013. J Clin Oncol. 2016 07 10; 34(20):2359-65. PMID: 27001590; PMCID: PMC4981976.
    Citations: 26     Fields:    Translation:Humans
  133. Piscuoglio S, Ng CK, Murray MP, Guerini-Rocco E, Martelotto LG, Geyer FC, Bidard FC, Berman S, Fusco N, Sakr RA, Eberle CA, De Mattos-Arruda L, Macedo GS, Akram M, Baslan T, Hicks JB, King TA, Brogi E, Norton L, Weigelt B, Hudis CA, Reis-Filho JS. The Genomic Landscape of Male Breast Cancers. Clin Cancer Res. 2016 Aug 15; 22(16):4045-56. PMID: 26960396; PMCID: PMC4987160.
    Citations: 51     Fields:    Translation:Humans
  134. Pilewskie M, Karsten M, Radosa J, Eaton A, King TA. Is Sentinel Lymph Node Biopsy Indicated at Completion Mastectomy for Ductal Carcinoma In Situ? Ann Surg Oncol. 2016 07; 23(7):2229-34. PMID: 26960927; PMCID: PMC4943570.
    Citations: 2     Fields:    Translation:Humans
  135. Waks AG, King TA, Winer EP. Timeliness in Breast Cancer Treatment-The Sooner, the Better. JAMA Oncol. 2016 Mar; 2(3):302-4. PMID: 26658500.
    Citations: 6     Fields:    Translation:Humans
  136. Reyes SA, King TA, Fei K, Franco R, Bickell NA. Factors Affecting the Completion of Adjuvant Chemotherapy in Early-Stage Breast Cancer. Ann Surg Oncol. 2016 May; 23(5):1537-42. PMID: 26714953.
    Citations: 7     Fields:    Translation:Humans
  137. Jhaveri K, Chandarlapaty S, Iyengar N, Morris PG, Corben AD, Patil S, Akram M, Towers R, Sakr RA, King TA, Norton L, Rosen N, Hudis C, Modi S. Biomarkers That Predict Sensitivity to Heat Shock Protein 90 Inhibitors. Clin Breast Cancer. 2016 08; 16(4):276-83. PMID: 26726007; PMCID: PMC5242238.
    Citations: 6     Fields:    Translation:Humans
  138. Sakr RA, Schizas M, Carniello JV, Ng CK, Piscuoglio S, Giri D, Andrade VP, De Brot M, Lim RS, Towers R, Weigelt B, Reis-Filho JS, King TA. Targeted capture massively parallel sequencing analysis of LCIS and invasive lobular cancer: Repertoire of somatic genetic alterations and clonal relationships. Mol Oncol. 2016 Feb; 10(2):360-70. PMID: 26643573.
    Citations: 16     Fields:    Translation:Humans
  139. Nakhlis F, Gilmore L, Gelman R, Bedrosian I, Ludwig K, Hwang ES, Willey S, Hudis C, Iglehart JD, Lawler E, Ryabin NY, Golshan M, Schnitt SJ, King TA. Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In-situ in Patients with Lobular Neoplasia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 020). Ann Surg Oncol. 2016 Mar; 23(3):722-8. PMID: 26542585; PMCID: PMC4984674.
    Citations: 14     Fields:    Translation:Humans
  140. Ciriello G, Gatza ML, Beck AH, Wilkerson MD, Rhie SK, Pastore A, Zhang H, McLellan M, Yau C, Kandoth C, Bowlby R, Shen H, Hayat S, Fieldhouse R, Lester SC, Tse GM, Factor RE, Collins LC, Allison KH, Chen YY, Jensen K, Johnson NB, Oesterreich S, Mills GB, Cherniack AD, Robertson G, Benz C, Sander C, Laird PW, Hoadley KA, King TA, Perou CM. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 08; 163(2):506-19. PMID: 26451490; PMCID: PMC4603750.
    Citations: 764     Fields:    Translation:HumansCells
  141. King TA, Pilewskie M, Morrow M. Optimal surgical management for high-risk populations. Breast. 2015 Nov; 24 Suppl 2:S91-5. PMID: 26432360.
    Citations: 3     Fields:    Translation:Humans
  142. King TA, Pilewskie M, Muhsen S, Patil S, Mautner SK, Park A, Oskar S, Guerini-Rocco E, Boafo C, Gooch JC, De Brot M, Reis-Filho JS, Morrogh M, Andrade VP, Sakr RA, Morrow M. Lobular Carcinoma in Situ: A 29-Year Longitudinal Experience Evaluating Clinicopathologic Features and Breast Cancer Risk. J Clin Oncol. 2015 Nov 20; 33(33):3945-52. PMID: 26371145; PMCID: PMC4934644.
    Citations: 45     Fields:    Translation:HumansPHPublic Health
  143. Karsten M, Stempel M, Radosa J, Patil S, King TA. Oncotype DX in Bilateral Synchronous Primary Invasive Breast Cancer. Ann Surg Oncol. 2016 Feb; 23(2):471-6. PMID: 26340863; PMCID: PMC4720549.
    Citations: 5     Fields:    Translation:Humans
  144. Janiszewska M, Liu L, Almendro V, Kuang Y, Paweletz C, Sakr RA, Weigelt B, Hanker AB, Chandarlapaty S, King TA, Reis-Filho JS, Arteaga CL, Park SY, Michor F, Polyak K. In situ single-cell analysis identifies heterogeneity for PIK3CA mutation and HER2 amplification in HER2-positive breast cancer. Nat Genet. 2015 Oct; 47(10):1212-9. PMID: 26301495; PMCID: PMC4589505.
    Citations: 78     Fields:    Translation:Humans
  145. Matsen CB, Mehrara B, Eaton A, Capko D, Berg A, Stempel M, Van Zee KJ, Pusic A, King TA, Cody HS, Pilewskie M, Cordeiro P, Sclafani L, Plitas G, Gemignani ML, Disa J, El-Tamer M, Morrow M. Skin Flap Necrosis After Mastectomy With Reconstruction: A Prospective Study. Ann Surg Oncol. 2016 Jan; 23(1):257-64. PMID: 26193963; PMCID: PMC4697877.
    Citations: 29     Fields:    Translation:Humans
  146. King TA, Morrow M. Surgical issues in patients with breast cancer receiving neoadjuvant chemotherapy. Nat Rev Clin Oncol. 2015 Jun; 12(6):335-43. PMID: 25850554.
    Citations: 47     Fields:    Translation:Humans
  147. Andrade VP, Morrogh M, Qin LX, Olvera N, Giri D, Muhsen S, Sakr RA, Schizas M, Ng CK, Arroyo CD, Brogi E, Viale A, Morrow M, Reis-Filho JS, King TA. Gene expression profiling of lobular carcinoma in situ reveals candidate precursor genes for invasion. Mol Oncol. 2015 Apr; 9(4):772-82. PMID: 25601220.
    Citations: 12     Fields:    Translation:HumansCells
  148. Newman LA, Reis-Filho JS, Morrow M, Carey LA, King TA. The 2014 Society of Surgical Oncology Susan G. Komen for the Cure Symposium: triple-negative breast cancer. Ann Surg Oncol. 2015 Mar; 22(3):874-82. PMID: 25527230.
    Citations: 40     Fields:    Translation:Humans
  149. Oppong BA, Pharmer LA, Oskar S, Eaton A, Stempel M, Patil S, King TA. The effect of metformin on breast cancer outcomes in patients with type 2 diabetes. Cancer Med. 2014 Aug; 3(4):1025-34. PMID: 24944108.
    Citations: 20     Fields:    Translation:Humans
  150. Gooch J, King TA, Eaton A, Dengel L, Stempel M, Corben AD, Morrow M. The extent of extracapsular extension may influence the need for axillary lymph node dissection in patients with T1-T2 breast cancer. Ann Surg Oncol. 2014 Sep; 21(9):2897-903. PMID: 24777858.
    Citations: 25     Fields:    Translation:Humans
  151. Pilewskie M, King TA. Magnetic resonance imaging in patients with newly diagnosed breast cancer: a review of the literature. Cancer. 2014 Jul 15; 120(14):2080-9. PMID: 24752817.
    Citations: 10     Fields:    Translation:Humans
  152. King TA, Reis-Filho JS. Lobular neoplasia. Surg Oncol Clin N Am. 2014 Jul; 23(3):487-503. PMID: 24882347.
    Citations: 7     Fields:    Translation:Humans
  153. Fackler MJ, Lopez Bujanda Z, Umbricht C, Teo WW, Cho S, Zhang Z, Visvanathan K, Jeter S, Argani P, Wang C, Lyman JP, de Brot M, Ingle JN, Boughey J, McGuire K, King TA, Carey LA, Cope L, Wolff AC, Sukumar S. Novel methylated biomarkers and a robust assay to detect circulating tumor DNA in metastatic breast cancer. Cancer Res. 2014 Apr 15; 74(8):2160-70. PMID: 24737128.
    Citations: 72     Fields:    Translation:HumansCells
  154. Pilewskie M, King TA. Age and molecular subtypes: impact on surgical decisions. J Surg Oncol. 2014 Jul; 110(1):8-14. PMID: 24691763.
    Citations: 5     Fields:    Translation:Humans
  155. Sakr RA, Weigelt B, Chandarlapaty S, Andrade VP, Guerini-Rocco E, Giri D, Ng CK, Cowell CF, Rosen N, Reis-Filho JS, King TA. PI3K pathway activation in high-grade ductal carcinoma in situ--implications for progression to invasive breast carcinoma. Clin Cancer Res. 2014 May 01; 20(9):2326-37. PMID: 24634376.
    Citations: 27     Fields:    Translation:HumansCells
  156. Toy W, Shen Y, Won H, Green B, Sakr RA, Will M, Li Z, Gala K, Fanning S, King TA, Hudis C, Chen D, Taran T, Hortobagyi G, Greene G, Berger M, Baselga J, Chandarlapaty S. ESR1 ligand-binding domain mutations in hormone-resistant breast cancer. Nat Genet. 2013 Dec; 45(12):1439-45. PMID: 24185512.
    Citations: 457     Fields:    Translation:HumansAnimalsCells
  157. McLaughlin S, Mittendorf EA, Bleicher RJ, McCready DR, King TA. The 2013 Society of Surgical Oncology Susan G. Komen for the Cure Symposium: MRI in breast cancer: where are we now? Ann Surg Oncol. 2014 Jan; 21(1):28-36. PMID: 24145992.
    Citations: 4     Fields:    Translation:Humans
  158. King TA, Muhsen S, Patil S, Koslow S, Oskar S, Park A, Morrogh M, Sakr RA, Morrow M. Is there a role for routine screening MRI in women with LCIS? Breast Cancer Res Treat. 2013 Nov; 142(2):445-53. PMID: 24141896.
    Citations: 11     Fields:    Translation:HumansPHPublic Health
  159. Moo TA, Choi L, Culpepper C, Olcese C, Heerdt A, Sclafani L, King TA, Reiner AS, Patil S, Brogi E, Morrow M, Van Zee KJ. Impact of margin assessment method on positive margin rate and total volume excised. Ann Surg Oncol. 2014 Jan; 21(1):86-92. PMID: 24046114.
    Citations: 9     Fields:    Translation:Humans
  160. Boafo C, Eaton A, Stempel M, Reis-Filho J, King TA. Invasive micropapillary breast cancer: Single-institution experience in the modern era. J Clin Oncol. 2013 Sep 10; 31(26_suppl):150. PMID: 28136560.
    Citations:    
  161. Dengel LT, Van Zee KJ, King TA, Stempel M, Cody HS, El-Tamer M, Gemignani ML, Sclafani LM, Sacchini VS, Heerdt AS, Plitas G, Junqueira M, Capko D, Patil S, Morrow M. Axillary dissection can be avoided in the majority of clinically node-negative patients undergoing breast-conserving therapy. Ann Surg Oncol. 2014 Jan; 21(1):22-7. PMID: 23975314.
    Citations: 36     Fields:    Translation:Humans
  162. Murphy JO, Moo TA, King TA, Van Zee KJ, Villegas KA, Stempel M, Eaton A, St Germain JM, Morris E, Morrow M. Radioactive seed localization compared to wire localization in breast-conserving surgery: initial 6-month experience. Ann Surg Oncol. 2013 Dec; 20(13):4121-7. PMID: 23943024.
    Citations: 15     Fields:    Translation:Humans
  163. Cadoo KA, Traina TA, King TA. Advances in molecular and clinical subtyping of breast cancer and their implications for therapy. Surg Oncol Clin N Am. 2013 Oct; 22(4):823-40. PMID: 24012401.
    Citations: 12     Fields:    Translation:HumansAnimals
  164. Cowell CF, Weigelt B, Sakr RA, Ng CK, Hicks J, King TA, Reis-Filho JS. Progression from ductal carcinoma in situ to invasive breast cancer: revisited. Mol Oncol. 2013 Oct; 7(5):859-69. PMID: 23890733.
    Citations: 95     Fields:    Translation:Humans
  165. Koslow S, Pharmer LA, Scott AM, Stempel M, Morrow M, Pusic AL, King TA. Long-term patient-reported satisfaction after contralateral prophylactic mastectomy and implant reconstruction. Ann Surg Oncol. 2013 Oct; 20(11):3422-9. PMID: 23720070.
    Citations: 33     Fields:    Translation:Humans
  166. Fuhrman GM, King TA. Multidisciplinary breast management. Surg Clin North Am. 2013 Apr; 93(2):xvii-xviii. PMID: 23464702.
    Citations: 1     Fields:    Translation:Humans
  167. Degnim AC, King TA. Surgical management of high-risk breast lesions. Surg Clin North Am. 2013 Apr; 93(2):329-40. PMID: 23464689.
    Citations: 15     Fields:    Translation:Humans
  168. Chandarlapaty S, Sakr RA, Giri D, Patil S, Heguy A, Morrow M, Modi S, Norton L, Rosen N, Hudis C, King TA. Frequent mutational activation of the PI3K-AKT pathway in trastuzumab-resistant breast cancer. Clin Cancer Res. 2012 Dec 15; 18(24):6784-91. PMID: 23092874.
    Citations: 91     Fields:    Translation:HumansCells
  169. Muhsen S, Andrade VP, Koslow Mautner S, Murray M, Giri DD, Sakr RA, Brogi E, King TA. Pleomorphic lobular carcinoma in situ: A distinct entity of controversial significance. J Clin Oncol. 2012 Sep 20; 30(27_suppl):177.